Join the Cervical Cancer group to help and get support from people like you.
Cervical Cancer News (Page 2)
Related terms: Cancer, Cervix
Cervical Cancer Deaths Fell Dramatically After Advent of HPV Vaccine
MONDAY, Dec. 2, 2024 – A new study provides good evidence that the human papillomavirus (HPV) vaccine may be achieving its goal of slashing rates of cervical cancer. “We observed a … 62% drop in cer...
Women Want a Choice Between Vaginal HPV Self-Sampling and Clinician Screen
THURSDAY, Oct. 24, 2024 – Most women would like a choice between vaginal human papillomavirus (HPV) self-sampling and traditional clinician screening, although nearly half would prefer a...
AAO: Corneal Toxicity Reported With Mirvetuximab Soravtansine
TUESDAY, Oct. 22, 2024 – For patients receiving mirvetuximab soravtansine (MIRV) treatment for primary gynecologic malignancies, corneal toxicity is not uncommon, but usually resolves, according to...
Measures of Social Support Linked to Cancer Screening
MONDAY, Oct. 21, 2024 – Measures of social support are associated with screening for specific types of cancer, according to a study published online Oct. 18 in Cancer Causes & Control. Jordan Baeker...
New Drug Regimen Extends Survival for Cervical Cancer Patients
THURSDAY, Oct. 17, 2024 – In some good news for women battling locally advanced cervical cancer, new research shows that adding six weeks of chemotherapy to standard treatment cuts the risk of death...
MS Might Raise a Person's Odds for Cancer
THURSDAY, Oct. 10, 2024b – There's a small but significant increased of certain cancers in people battling multiple sclerosis (MS), new research shows. Those malignancies include cancers of the...
One-Dose HPV Vaccination Averts Similar Number of Cancers as Two Doses
MONDAY, Oct. 7, 2024 – A one-dose human papillomavirus (HPV) vaccination program is projected to prevent a similar number of cervical cancers as a two-dose program, according to a study published...
U.S. Cancer Incidence Trends Lower Than Expected in 2021
FRIDAY, Sept. 6, 2024 – U.S. cancer incidence trends improved in 2021, but continued to be lower than expected, according to a study published online Sept. 6 in JAMA Network Open. Todd Burus, from...
U.S. Spends $43 Billion Annually on Cancer Screening
TUESDAY, Aug. 6, 2024 – Screening for cancer saves lives, but a new report shows it comes with a hefty price tag: The United States spends at least $43 billion annually on tests that check for five...
2007 to 2020 Saw Continuous Decrease in Cervical Cancer in Younger Women
MONDAY, Aug. 5, 2024 – For individuals younger than 25 years, the incidence of cervical intraepithelial neoplasia (CIN) decreased continuously from 2007 through 2020, according to a research letter...
Noninvasive Urine Test for Cervical Cancer Shows Promise
TUESDAY, July 9, 2024 – A new urine test might help doctors more easily screen for cervical cancer, researchers report. The test looks for proteins generated by a type of cancer-causing human...
Tisotumab Vedotin Efficacious for Recurrent Cervical Cancer
MONDAY, July 8, 2024 – Second- or third-line treatment with tisotumab vedotin is efficacious for patients with recurrent cervical cancer, according to a study published in the July 4 issue of the...
FDA Grants Full Approval for Tivdak to Treat Recurrent or Metastatic Cervical Cancer
NEW YORK & COPENHAGEN, Denmark--(BUSINESS WIRE) April 29, 2024 – Pfizer Inc. (NYSE: PFE) and Genmab A/S (Nasdaq: GMAB) today announced the U.S. Food and Drug Administration (FDA) approves the...
FDA Approves Merck’s Keytruda (pembrolizumab) Plus Chemoradiotherapy as Treatment for Patients With FIGO 2014 Stage III-IVA Cervical Cancer
Keytruda is the first and only anti-PD-1 therapy approved in combination with chemoradiotherapy for these patients Approval marks third FDA-approved indication for Keytruda in cervical cancer and...
FDA Approves Vegzelma (bevacizumab-adcd), a Biosimilar to Avastin
Vegzelma is Celltrion’s third oncology biosimilar to receive approval from the U.S. FDA Vegzelma offers U.S. patients living with multiple types of cancer a new, safe, and effective treatment option ...